UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection

Gastroenterology (New York, N.Y. 1943), 2016-07, Vol.151 (1), p.110-119

2016

Volltextzugriff (PDF)

Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn’s Disease Patients Failing Infliximab

Digestive diseases and sciences, 2015-09, Vol.60 (9), p.2762-2770

2015

Volltextzugriff (PDF)

The NIMO Scandinavian Study: A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron Deficiency

Gastroenterology research and practice, 2017-01, Vol.2017, p.4585164-7

2017

Volltextzugriff (PDF)

Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial

Gut, 2014-06, Vol.63 (6), p.919-927

2014

Volltextzugriff (PDF)

Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study

The American journal of gastroenterology, 2013-12, Vol.108 (12), p.1869-1876

2013

Volltextzugriff (PDF)

Has the Incidence of Inflammatory Bowel Disease Peaked? Evidence From the Population-Based NorDIBD Cohort 1978-2020

The American journal of gastroenterology, 2023-03, Vol.118 (3), p.501-510

2023

Volltextzugriff (PDF)

Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease

Inflammatory bowel diseases, 2017-07, Vol.23 (7), p.1240-1246

2017

Volltextzugriff (PDF)

Less prevalent use of biologics for inflammatory bowel disease in patients from Non-Academic hospitals - a Danish register-based study of a region with 580,000 citizens

Scandinavian journal of gastroenterology, 2023-05, Vol.58 (5), p.477-482

2023

Volltextzugriff (PDF)

T1119 Long-Term Budesonide Treatment of Collagenous Colitis - a Randomized, Double Blind, Placebo Controlled Trial

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-487-A-488

2008

Volltextzugriff (PDF)

Touch screens as a tool in patient care in the IBD outpatient clinic

Scandinavian journal of gastroenterology, 2016-09, Vol.51 (9), p.1106-1110

2016

Volltextzugriff (PDF)

Timing of Live Attenuated Vaccination in Infants Exposed to Infliximab or Adalimumab in Utero: A Prospective Cohort Study in 107 Children

Journal of Crohn's and colitis, 2022-12, Vol.16 (12), p.1835-1844

2022

Volltextzugriff (PDF)

Changing Infliximab Prescription Patterns in Inflammatory Bowel Disease: A Population-Based Cohort Study, 1999-2014

Inflammatory bowel diseases, 2018-01, Vol.24 (2), p.433-439

2018

Volltextzugriff (PDF)

Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial

The lancet. Gastroenterology & hepatology, 2022-04, Vol.7 (4), p.294-306

2022

Volltextzugriff (PDF)

Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978–2002

European journal of gastroenterology & hepatology, 2006-06, Vol.18 (6), p.601-606

2006

Volltextzugriff (PDF)

A Proposal for a Study on Treatment Selection and Lifestyle Recommendations in Chronic Inflammatory Diseases: A Danish Multidisciplinary Collaboration on Prognostic Factors and Personalised Medicine

Nutrients, 2017-05, Vol.9 (5), p.499

2017

Volltextzugriff (PDF)

Impact of red and processed meat and fibre intake on treatment outcomes among patients with chronic inflammatory diseases: protocol for a prospective cohort study of prognostic factors and personalised medicine

BMJ open, 2018-02, Vol.8 (2), p.e018166-e018166

2018

Volltextzugriff (PDF)

Sa1268 Individualized Therapy Is Long-Term Cost-Effective Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-277-S-277

2015

Volltextzugriff (PDF)

540 Adalimumab and Infliximab Levels in Neonates (ERA Study)

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-108-S-108

2015

Volltextzugriff (PDF)

Tu1142 Secondary Infliximab Treatment Failure in Crohn's Disease: Therapeutic Implications of Measuring Drug and Anti-Drug Antibodies by Three Different Binding Assays

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-773-S-773

2013

Volltextzugriff (PDF)

Biologic therapy in inflammatory bowel disease

Danish medical journal, 2013-06, Vol.60 (6), p.B4652

2013

Volltextzugriff (PDF)

Comparison of Techniques for Monitoring Infliximab and Antibodies to Infliximab in Crohnʼs Disease Patients with Infliximab Treatment Failure: 1546

The American journal of gastroenterology, 2012-10, Vol.107, p.S622

2012

Volltextzugriff (PDF)

94 Treatment of Secondary Infliximab Failure in Crohn's Disease Based on Serum Levels of Infliximab and Antibodies Against Infliximab: The Danish Study of Optimizing Infliximab Therapy in Crohn's Disease (Do It Crohn) Randomized Clinical Trial

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-22-S-22

2013

Volltextzugriff (PDF)

Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease

Danish medical journal, 2015-01, Vol.62 (1), p.B4995

2015

Volltextzugriff (PDF)

Measurement of Gastrointestinal pH and Regional Transit Times in Normal Children

Journal of pediatric gastroenterology and nutrition, 1990-08, Vol.11 (2), p.211-214

1990

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(42)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Humans
(28)
Gastroenterology & Hepatology
(20)
Female
(17)
Adult
(16)
Male
(15)
Inflammatory Bowel Disease
(11)
Adolescent
(7)
Biological And Medical Sciences
(7)
Denmark
(7)
General & Internal Medicine
(7)
Medicine, General & Internal
(7)
Middle Aged
(7)
Aged
(6)
Gastroenterology And Hepatology
(6)
Inflammatory Bowel Diseases - Drug Therapy
(6)
Medical Sciences
(6)
Crohn Disease - Drug Therapy
(5)
Pregnancy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection

Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn’s Disease Patients Failing Infliximab

The NIMO Scandinavian Study: A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron Deficiency

Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial

Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study

Has the Incidence of Inflammatory Bowel Disease Peaked? Evidence From the Population-Based NorDIBD Cohort 1978-2020

Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease

Less prevalent use of biologics for inflammatory bowel disease in patients from Non-Academic hospitals - a Danish register-based study of a region with 580,000 citizens

T1119 Long-Term Budesonide Treatment of Collagenous Colitis - a Randomized, Double Blind, Placebo Controlled Trial

Touch screens as a tool in patient care in the IBD outpatient clinic

Timing of Live Attenuated Vaccination in Infants Exposed to Infliximab or Adalimumab in Utero: A Prospective Cohort Study in 107 Children

Changing Infliximab Prescription Patterns in Inflammatory Bowel Disease: A Population-Based Cohort Study, 1999-2014

Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial

Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes

Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978–2002

A Proposal for a Study on Treatment Selection and Lifestyle Recommendations in Chronic Inflammatory Diseases: A Danish Multidisciplinary Collaboration on Prognostic Factors and Personalised Medicine

Impact of red and processed meat and fibre intake on treatment outcomes among patients with chronic inflammatory diseases: protocol for a prospective cohort study of prognostic factors and personalised medicine

Sa1268 Individualized Therapy Is Long-Term Cost-Effective Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab

540 Adalimumab and Infliximab Levels in Neonates (ERA Study)

Tu1142 Secondary Infliximab Treatment Failure in Crohn's Disease: Therapeutic Implications of Measuring Drug and Anti-Drug Antibodies by Three Different Binding Assays

Biologic therapy in inflammatory bowel disease

Comparison of Techniques for Monitoring Infliximab and Antibodies to Infliximab in Crohnʼs Disease Patients with Infliximab Treatment Failure: 1546

94 Treatment of Secondary Infliximab Failure in Crohn's Disease Based on Serum Levels of Infliximab and Antibodies Against Infliximab: The Danish Study of Optimizing Infliximab Therapy in Crohn's Disease (Do It Crohn) Randomized Clinical Trial

Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease

Measurement of Gastrointestinal pH and Regional Transit Times in Normal Children

Suchergebnisse filtern